ImmunityBio stock jumps after strong trial updates in bladder cancer and lymphoma, with enrollment ahead of schedule and FDA ...

The lifecycle of a medical device is under renewed regulatory and commercial scrutiny. Although lifetime expectations are not ...

AI-augmented research can speed up processes such as literature review and data synthesis. Here, Ali Shiri looks at ...

Topline data from CHAPTER-3, a pivotal study of deucrictibant for prophylactic treatment of HAE attacks, anticipated in 3Q2026Preparation of NDA dossier of deucrictibant for on-demand treatment of HAE ...

Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...

Planned Review of Standard Deviation Demonstrates No Need to Increase Size of Ongoing LEVEL Study LEVEL On Track to Complete Enrollment in First Half of 2026; Topline Data Expected in Second Half of ...

Detailed price information for Theriva Biologics Inc (TOVX-A) from The Globe and Mail including charting and trades.

Planned Review of Standard Deviation Demonstrates No Need to Increase Size of Ongoing LEVEL Study LEVEL On Track to Complete Enrollment in First Half of 2026; Topline Data Expected in Second Half of ...

Aim To evaluate the effectiveness of atropine 0.01% in young premyopic and low-myopic children. Methods Children (5–9 years old) with premyopia (spherical equivalent refraction, SER+1.00 to −0.49D, n ...

MELBOURNE, AUSTRALIA, November 20, 2025 /EINPresswire.com/ -- iNGENū CRO has unveiled a global clinical trial model it says can deliver the same regulatory rigor and ...

Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, ...

Purpose To determine the effects of advanced spectacle lens technologies on changes in spherical equivalent of refraction (SER) and axial length (AL) elongation in slowing down the progression of ...